FDA Inspection
Padagis US LLCPadagis US LLC – FDA Inspection, Sep 6, 2024
Record Details
This FDA Inspection record concerns Padagis US LLC, with an inspection on September 6, 2024, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · 97b56ca5-bc97-4f15-a812-d63d66078fa5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1248645
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.67(b)(6)Cleaning SOP/inspection
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Padagis US LLC
11| Date | Classification | Office | Project area |
|---|---|---|---|
| April 8, 2026 | Not classified | Minneapolis District Office | Drug Quality Assurance |
| January 31, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 5, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 18, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 23, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Padagis US LLC
- FDA Inspection 1304064 - 2026-04-08
- FDA Inspection 1228870 - 2024-01-31
- FDA Inspection 1207462 - 2023-05-05
- FDA Inspection 1162776 - 2022-02-18
- FDA Inspection 1108752 - 2019-10-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.